Friday April 03, Barcelona

01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
Gut microbiota (GMB) and osteoarthritis (OA) management: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing.
Chairpersons: Islene Araujo de Carvalho, Francis Berenbaum
Introduction Emmanuel Biver
Gut microbiota and inflammation Claudio Franceschi
Role of gut microbiota in non-communicable disease and osteoarthritis management Emmanuel Biver
Discussion Francis Berenbaum

09.00 - 10.30
SCIENTIFIC SESSION I
Chairpersons: Cyrus Cooper, René Rizzoli
09.00
Plenary Lecture 1
Transient treatment discontinuation : pros and cons Michael R. McClung
09.30
Oral communication selected from abstracts
10.30 - 12.00
SCIENTIFIC SESSION II
Chairpersons: Jean‑Yves Reginster, John A. Kanis
10.30
Presentation of the ESCEO-IOF Herbert Fleisch Medal
10.40
Plenary Lecture 2
Differences in clinical guidelines Eugene McCloskey
11.10
Presentation of the IOF President's Award
11.20
Oral communication selected from abstracts
14.00 - 15.00
Poster Viewing Session I
14.00 - 15.00
Oral presentation of selected posters
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Discussion of complex osteoporotic cases
Adolfo Diez‑Perez
Management of CKD-MBD
Jorge Cannata Andia
Nutritional approach of osteoporosis prevention
Stefania Maggi
GIOP : what to do ?
Emmanuel Biver
Pharmacoepidemiology of musculoskeletal disease
Daniel Prieto‑Alhambra
14.00 - 15.00
Alternative treatments for osteoarthritis: stem cells, platelet-rich plasma, autologous chondrocyte transplantation, ...: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: Willem Lems, Francis Berenbaum
Introduction and scope of the problem Emmanuel Maheu
Role of surgical regenerative therapies in the management of knee osteoarthritis Richard Oreffo
Role of "alternative" treatments of knee osteoarthritis Nicholas R. Fuggle
Discussion Jean‑François Kaux

15.00 - 17.00
SCIENTIFIC SESSION III
Chairpersons: Nicholas Harvey, Bess Dawson‑Hughes
15.00
Plenary Lecture 3
Rare bone diseases : what do they teach us for musculoskeletal disorders management Kassim Javaid
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 4
New pharmacological treatments for osteoarthritis Elaine M. Dennison
15.00 - 16.45
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION